It can also promote the occurrence and development of tumors through the regulation of Oct4, and the high expressions of Oct4, NEAT1, and MALAT1 are related to the poor prognosis of NSCLC patients, and its HR = 2.78 (95%CI: 1.21–6.42) [9]. This evidence concerns the gene NEAT1 and non-small cell lung carcinoma.